SCHEMBL18556934

SCHEMBL18556934

CCC(C)c1n[nH]c2cc(C(F)(F)F)ccc12

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.50
▸ TRPA1 O75762 4/20 0.47
▸ MAP2K4 P45985 3/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ MAPK6 Q16659 2/20 0.44
▸ MAPKAPK5 Q8IW41 1/20 0.44
▸ KIF11 P52732 6/20 0.42
▸ KCNQ3 O43525 1/20 0.41
▸ KCNQ2 O43526 1/20 0.41
▸ KCNQ1 P51787 1/20 0.41
▸ SCN5A Q14524 1/20 0.41
▸ MAPKAPK2 P49137 1/20 0.39
▸ MAPKAPK3 Q16644 1/20 0.39
▸ METAP2 P50579 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.37
▸ ITK Q08881 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16675888 0.85 TRPA1 (0.51) GSK3BTRPA1MAP2K4MAPK1MAPK6
SCHEMBL24991937 0.78 KIF11 (0.41) GSK3BMAP2K4KIF11METAP2HSD17B10
SCHEMBL5678040 0.76 GSK3B (0.54) GSK3BTRPA1MAP2K4MAPK1MAPK6
SCHEMBL13122227 0.73 TRPA1 (0.55) GSK3BTRPA1MAP2K4MAPK1MAPK6
SCHEMBL13948936 0.73 KDM4E (0.46) —
SCHEMBL19308854 0.73 KDM4E (0.46) —
SCHEMBL15723643 0.73 MAP2K4 (0.52) GSK3BTRPA1MAP2K4MAPK1MAPK6
SCHEMBL2662677 0.72 TRPA1 (0.56) GSK3BTRPA1MAP2K4MAPK1MAPK6
SCHEMBL10220256 0.71 KIF11 (0.56) GSK3BTRPA1MAP2K4MAPK1MAPK6
SCHEMBL18806114 0.71 KIF11 (0.44) GSK3BTRPA1KIF11ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580391-B2 Saturated acyl guanidine for inhibition of F1F0-ATPase LYCERA CORPORATION (US) 2017-02-28 — — US disclosed
Send feedback